Gottlieb skewers US drug pricing: “It’s time to stop the shell games”
Ontruzant, the first biosimilar version of Roche’s Herceptin (trastuzumab) in Europe has been launched in the UK by MSD.
The chairman of a pan-European pharma group says he is still optimistic that a Brexit deal can be struck, despite the head of the European Council rejecting British plans for future alignment.
Ahead of his talk at EyeforPharma Barcelona next week, Medscape’s Ben Greenberg talks to pharmaphorum about the hype surrounding technology, and offers ideas about how to identify meaningful innovation.
Amryt looking to expand rare disease franchise
Owlstone Medical, the innovative company which promises to revolutionise the diagnosis of cancer by simply analysing a patient’s breath has been given a major funding boost.